Skip to Content
Morningstar

KraneShares MSCI All China Hlth Care ETF KURE

Morningstar Medalist Rating
Medalist Rating as of | See Kraneshares Investment Hub

Morningstar’s Analysis KURE

Will KURE outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable KURE’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the KURE management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of KURE’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of a middling Process Pillar rating and a Low People Pillar rating limit KraneShares MSCI All China Hlth Care ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings KURE

More KURE Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 45.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A

9.10 3.5 Mil
Healthcare

Jiangsu Hengrui Pharmaceuticals Co Ltd Class A

7.29 2.8 Mil
Healthcare

BeiGene Ltd Ordinary Shares

5.44 2.1 Mil
Healthcare

CSPC Pharmaceutical Group Ltd

4.16 1.6 Mil
Healthcare

Innovent Biologics Inc

3.87 1.5 Mil
Healthcare

Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A

3.45 1.3 Mil
Healthcare

WuXi Biologics (Cayman) Inc

3.42 1.3 Mil
Healthcare

Legend Biotech Corp ADR

2.87 1.1 Mil
Healthcare

Wuxi AppTec Co Ltd Class A

2.74 1.0 Mil
Healthcare

Aier Eye Hospital Group Co Ltd Class A

2.64 1.0 Mil
Healthcare